Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc

QR Code

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc

Eva Poveda, Vincent SorianoDepartment of Infectious Diseases, Hospital Carlos III, Madrid, SpainAbstract: Maraviroc is the first CCR5 antagonist approved for the treatment of HIV-1 infection. It specifically inhibits the replication of R5 viruses by blocking viral entry. HIV-1 tropism can be estimat...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Eva Poveda, Vincent Soriano
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/d00e38efa01d416dbaedef85485721bf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
par: Thore Lorenzen
Publié: (2010)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
par: Putcharoen O, et autres
Publié: (2013)

Magnitude of cytopenias among HIV‑infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART‑experienced children
par: Tsegay YG, et autres
Publié: (2017)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
par: Nanzigu S, et autres
Publié: (2013)

Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir
par: D&#39;Ambrosio R, et autres
Publié: (2012)

Profile of darunavir in the management of treatment-experienced HIV patients
par: Cameron Wolfe, et autres
Publié: (2009)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
par: Osterholzer D
Publié: (2013)

The effectiveness of pictogram intervention in the identification and reporting of adverse drug reactions in naïve HIV patients in Ethiopia: a cross-sectional study
par: Gebreyohannes EA, et autres
Publié: (2019)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
par: Michael A Horberg, et autres
Publié: (2010)

Nontyphoidal Salmonella bacteremia in antiretroviral therapy-naïve HIV-infected individuals at three public hospitals in Eastern Ethiopia: prevalence, antimicrobial susceptibility patterns, and associated factors
par: Mitiku H, et autres
Publié: (2019)

Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1
par: Rolando M Viani
Publié: (2010)

The use of preexposure treatments for HIV prophylaxis
par: Majid A, et autres
Publié: (2012)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
par: Pandey KK
Publié: (2014)

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
par: Patel TS, et autres
Publié: (2013)

Long-term treatment of patients with HIV-1: the role of atazanavir
par: Miguel &Aacute;ngel Artacho, et autres
Publié: (2010)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
par: Beatriz Larru Martinez, et autres
Publié: (2010)

Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
par: Pullen SD, et autres
Publié: (2014)

Mucoadhesive Microspheres of Maraviroc and Tenofovir Designed for Pre-Exposure Prophylaxis of HIV-1: An in vitro Assessment of the Effect on Vaginal Lactic Acid Bacteria Microflora
par: Ekama SO, et autres
Publié: (2021)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
par: Seddon J, et autres
Publié: (2011)

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
par: Enriquez M, et autres
Publié: (2011)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
par: Zhou DT, et autres
Publié: (2015)

Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions
par: Lidia Elfstrand, et autres
Publié: (2010)

Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
par: Pefura Yone EW, et autres
Publié: (2012)

Evaluating the McDonald&#39;s business model for HIV prevention among truckers to improve program coverage and service utilization in India, 2004&ndash;2010
par: Tirumalasetti Rao V, et autres
Publié: (2013)

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
par: Jose A Vazquez
Publié: (2010)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
par: Dowers E, et autres
Publié: (2018)

New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
par: Patel N, et autres
Publié: (2012)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
par: Dubrocq G, et autres
Publié: (2018)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
par: Zamora FJ, et autres
Publié: (2019)

Biologic treatments in Behçet’s disease
par: Fatma Alibaz-Öner, et autres
Publié: (2021)

Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning &ndash; anxiety, depression, quality of life
par: Maureen E Lyon, et autres
Publié: (2010)

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
par: Alana MacDonald, et autres
Publié: (2021)

Perceptions of alcohol use in the context of HIV treatment: a qualitative study
par: Madhombiro M, et autres
Publié: (2018)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
par: Sicong Li, et autres
Publié: (2021)

Effect of once-daily FDC treatment era on initiation of cART
par: David M Mosen, et autres
Publié: (2010)

Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia
par: Demissie K, et autres
Publié: (2015)

Assessing the HIV rapid test in the fight against the HIV/AIDS epidemic in Trinidad
par: Mungrue K, et autres
Publié: (2013)

HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites
par: Nitin K Saksena, et autres
Publié: (2010)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
par: Luiz Felipe Domingues Passero, et autres
Publié: (2021)

Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
par: Crutchley RD, et autres
Publié: (2016)